0.00Open0.00Pre Close0 Volume0 Open Interest20.00Strike Price0.00Turnover337.80%IV-97.24%PremiumJan 17, 2025Expiry Date9.86Intrinsic Value100Multiplier10DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8235Delta0.0458Gamma0.98Leverage Ratio-0.0708Theta-0.0041Rho-0.80Eff Leverage0.0044Vega
KKR Real Estate Finance Trust Stock Discussion
• $Okta (OKTA.US)$ +15.8% (In reaction to earnings)
• $StoneCo (STNE.US)$ +12.9% (In reaction to earnings)
• $Turning Point Therapeutics (TPTX.US)$ +116.8% (Bristol Myers Squibb (BMY) will acquire Turning Point Therapeutics for $76,00 per share; expected to be accretive to Non-GAAP earnings per share beginningin2025)
• $Amylyx Pharmaceuticals (AMLX.US)$ +24.9% (receives PDUFA date extension for AMX0035; scheduled for September ...
No comment yet